"We probably do need to relook at how we can do catch-up".
The man is in Box Hill Hospital, in east Melbourne, after receiving the vaccine on 22 March, according to the ABC.
However, concerns continue to surface over the rollout of vaccines, with Queensland nearly out of the Pfizer inoculation and unsure when it will receive its next delivery.
"The risks of serious side effects remain very low", Professor Kidd said.
Malaysia has agreed to purchase 66.7 million doses of Covid-19 vaccines from various drug makers and plans to vaccinate at least 80% of the population by February next year.
"Given how consist of the clinical features are in this case, with some similar cases which have been seen overseas, it is likely that this case, which is reported, is related to the vaccine", he said.
The committee is expected to come with further information about the AstraZeneca vaccine.
Kidd advised healthcare workers to be aware of the condition.
Prof Kidd said expected side effects from either the Pfizer or AstraZeneca vaccines could include fever, sore muscles, tiredness and headache and that such symptoms could start about 24 hours after receiving the vaccine and last one to two days.
"My general feeling is that given the contractual relationships that we have with a number of companies, that we have enough vaccine to fulfill all of our needs without invoking AstraZeneca", he said.
The fresh reports in the United Kingdom lift the total number of cases to 30 as of March 24, the Medicines and Healthcare Products Regulatory Agency said in a statement Thursday.
Lareb said the events had occurred 7 to 10 days after vaccination.
Seven hundred and fifty thousand doses of Covid-19 vaccines have been administered across Australia as of midday Thursday.
It previously declared the AstraZeneca vaccine safe, just as the World Health Organization did.
A causal link with the AstraZeneca vaccine is yet to be established.
Some countries have restricted use of the AstraZeneca vaccine while others have resumed inoculations, as investigations into reports of rare, and sometimes severe, blood clots continue.
Earlier this week, the European Union drugs regulator said a link between the AstraZeneca vaccine and a rare type of blood clot is possible, identifying at least 62 cases of the condition.
New Zealand has prepurchase agreements with four Covid vaccine suppliers: Pfizer/BioNTech, Janssen Pharmaceutica, Novavax and AstraZeneca. In late March, CSL Ltd. began domestic production of 50 million doses.